India

In an effort to penetrate emerging markets, UK specialty drugmaker Sinclair Pharma has contracted Mumbai-based Wockhardt to distribute four of its products in India. The deal runs... 2008-06-30

India's Plethico Pharmaceuticals is targeting acquisitions in the US and Brazil in order to expand its Americas over-the-counter (OTC) and nutraceuticals businesses, according to... 2008-06-20

US-based Mylan has signed an agreement with India's NATCO Pharma to market a generic version of Israeli drugmaker Teva's multiple sclerosis drug Copaxone (glatiramer) in the US, Europe,... 2008-06-12

In an effort to diversify and increase its presence in emerging markets, Japanese drugmaker Daiichi Sankyo has purchased a controlling stake in Indian generics firm Ranbaxy Laboratories.... 2008-06-12

Indian generics firm Zydus Cadila has announced that it is to acquire 70% of South Africa's Simayla Pharmaceuticals, as part of its drive to penetrate southern Africa's generics markets.... 2008-06-10

In an effort to expand into South America and Western Europe, Indian healthcare provider Apollo Hospitals Group is evaluating acquisition targets in Peru and Spain. The group has... 2008-06-02

Surprising many industry observers, BMI included, on May 28 Israel's Taro Pharmaceutical Industries terminated its proposed merger with India's Sun Pharmaceutical Industries, bringing... 2008-05-29

Indian generics multinational Ranbaxy Laboratories has entered Yemen's pharmaceutical market through a tie up with Yemen's National Trading Company (Natco). The deal will see Natco... 2008-05-21

It is BMI's view that the diabetes epidemic in India represents a significant opportunity for drugmakers. The debilitating condition accounts for a large portion of the country's... 2008-05-08

To counter a 'lull' in US and Western Europe sales, GE Healthcare Life Sciences is targeting significantly increased demand in India for its tools that aid drug discovery. Over the... 2008-05-06